InspireMD, Inc.
NSPR
$1.94
-$0.04-2.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 41.90% | 16.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 41.90% | 16.29% | |||
| Cost of Revenue | 13.24% | 18.43% | |||
| Gross Profit | 176.04% | 7.19% | |||
| SG&A Expenses | 8.23% | 23.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.25% | 13.92% | |||
| Operating Income | -0.25% | -13.60% | |||
| Income Before Tax | 3.37% | -17.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.37% | -17.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.37% | -17.78% | |||
| EBIT | -0.25% | -13.60% | |||
| EBITDA | -0.09% | -13.64% | |||
| EPS Basic | 32.89% | -15.45% | |||
| Normalized Basic EPS | 32.94% | -15.47% | |||
| EPS Diluted | 32.89% | -15.45% | |||
| Normalized Diluted EPS | 32.94% | -15.47% | |||
| Average Basic Shares Outstanding | 44.04% | 2.02% | |||
| Average Diluted Shares Outstanding | 44.04% | 2.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||